Amarin Corp Plc (AMRN)

[ziploc_1]

The need to lower the price of Vascepa will eventually come from pressures from Europe and China...I'm therefore not concerned about lowering the price in the U.S....Vascepa was always intended to be more about volume than about price.

The market and the indications for Vascepa are so large, that Vascepa can be quite profitable at a lower price point...We do have to get the volume up first before this can happen.

I can see Vascepa being sold in lower income settings like India and Africa at lower prices in the future...At that point, the challenge will be to increase the supply of EPA...This will take a large investment to explore new avenues for the production of EPA.